232 related articles for article (PubMed ID: 36858169)
21. Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis.
Monjo-Henry I; Fernández-Fernández E; Mostaza JM; Lahoz C; Molina-Collada J; de Miguel E
Arthritis Res Ther; 2023 Feb; 25(1):23. PubMed ID: 36788547
[TBL] [Abstract][Full Text] [Related]
22. Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.
Molina-Collada J; Castrejón I; Monjo I; Fernández-Fernández E; Torres Ortiz G; Álvaro-Gracia JM; de Miguel E
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094980
[TBL] [Abstract][Full Text] [Related]
23. Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis.
Bellan M; Puta E; Croce A; Sacchetti GM; Orsini F; Zecca E; Soddu D; Gavelli F; Avanzi GC; Castello L; Pedrazzoli R; Sola D; Pirisi M; Sainaghi PP
Clin Rheumatol; 2020 Apr; 39(4):1277-1281. PubMed ID: 31713732
[TBL] [Abstract][Full Text] [Related]
24. Extracranial giant cell arteritis: A narrative review.
Lensen KD; Voskuyl AE; Comans EF; van der Laken CJ; Smulders YM
Neth J Med; 2016 Jun; 74(5):182-92. PubMed ID: 27323671
[TBL] [Abstract][Full Text] [Related]
25. Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020.
Skaug HK; Fevang BT; Assmus J; Diamantopoulos AP; Myklebust G; Brekke LK
Front Med (Lausanne); 2023; 10():1296393. PubMed ID: 38148911
[TBL] [Abstract][Full Text] [Related]
26. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.
Klink T; Geiger J; Both M; Ness T; Heinzelmann S; Reinhard M; Holl-Ulrich K; Duwendag D; Vaith P; Bley TA
Radiology; 2014 Dec; 273(3):844-52. PubMed ID: 25102371
[TBL] [Abstract][Full Text] [Related]
27. Giant cell arteritis.
Pepper K
Postgrad Med; 2023 Jan; 135(sup1):22-32. PubMed ID: 37021621
[TBL] [Abstract][Full Text] [Related]
28. The Immunopathology of Giant Cell Arteritis Across Disease Spectra.
Robinette ML; Rao DA; Monach PA
Front Immunol; 2021; 12():623716. PubMed ID: 33717128
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.
Assie C; Janvresse A; Plissonnier D; Levesque H; Marie I
Medicine (Baltimore); 2011 Jan; 90(1):40-51. PubMed ID: 21200185
[TBL] [Abstract][Full Text] [Related]
30. [Gynecologic vasculitis revealing a giant cell arteritis: A case report and literature review].
Guillotin V; Mercie P; Duffau P
Rev Med Interne; 2022 Mar; 43(3):181-184. PubMed ID: 35031140
[TBL] [Abstract][Full Text] [Related]
31. The incidence of giant cell arteritis in Slovenia.
Pucelj NP; Hočevar A; Ješe R; Rotar Ž; Hawlina M; Fakin A; Pižem J; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):285-290. PubMed ID: 30062445
[TBL] [Abstract][Full Text] [Related]
32. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
[TBL] [Abstract][Full Text] [Related]
33. Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease.
González-Gay MÁ; Heras-Recuero E; Blázquez-Sánchez T; Caraballo-Salazar C; Rengifo-García F; Castañeda S; Largo R
Expert Rev Clin Immunol; 2024 May; ():1-12. PubMed ID: 38757894
[TBL] [Abstract][Full Text] [Related]
34. Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study.
Yamaguchi E; Kadoba K; Watanabe R; Iwasaki T; Kitagori K; Akizuki S; Murakami K; Nakashima R; Hashimoto M; Tanaka M; Morinobu A; Yoshifuji H
Mod Rheumatol; 2023 Jan; 33(1):175-181. PubMed ID: 35141755
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.
Prior JA; Ranjbar H; Belcher J; Mackie SL; Helliwell T; Liddle J; Mallen CD
BMC Med; 2017 Jun; 15(1):120. PubMed ID: 28655311
[TBL] [Abstract][Full Text] [Related]
36. Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?
Molina Collada J; Martínez-Barrio J; Serrano-Benavente B; Castrejón I; Nieto-González JC; Caballero Motta LR; Trives Folguera L; Álvaro-Gracia JM
Clin Rheumatol; 2021 Jul; 40(7):2821-2827. PubMed ID: 33432449
[TBL] [Abstract][Full Text] [Related]
37. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
[TBL] [Abstract][Full Text] [Related]
38. Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT.
Molina-Collada J; Castrejón I; Monjo-Henry I; Fernández-Fernández E; Torres Ortiz G; Martínez-Barrio J; Álvaro-Gracia JM; de Miguel E
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37597848
[TBL] [Abstract][Full Text] [Related]
39. Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
Üsküdar Cansu D; Üsküdar Teke H; Korkmaz C
Rheumatol Int; 2021 Oct; 41(10):1803-1810. PubMed ID: 33156359
[TBL] [Abstract][Full Text] [Related]
40. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
